Summary by Moomoo AI
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) ISSUED ON 26 MARCH 2024 AN OVERSEAS REGULATORY NOTICE CONTAINING THE COMPANY'S “FUSTAR PHARMACEUTICALS: VERIFICATION OF THE STORAGE AND ACTUAL USE OF FUNDS” PUBLISHED BY THE COMPANY ON THE SHANGHAI STOCK EXCHANGE WEBSITE. The report is intended to provide investor reference and has not made any representations as to the accuracy or completeness of its contents by Hong Kong Trading and Settlement Limited and Hong Kong Stock Exchange Limited. THE CURRENT EXECUTIVE DIRECTORS OF FUSTAR PHARMACEUTICALS INCLUDE MR. WU YIFANG, MR. WANG KEXIN, MS. GUAN XIAHUI AND MR. WEN DE YUNG; THE NON-EXECUTIVE DIRECTORS ARE MR. CHEN QIYU, MR. YAO FANG, MR. XU XIAOLING AND MR. PAN TUNG HUI; THE INDEPENDENT NON-EXECUTIVE DIRECTORS INCLUDE MS. LI LING, MR. YANG GUAN LIANG, MR. WANG CHUAN AND ZHI Mr. Shan.